Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial DiseasesPablo García‐Pavía, Aleš Linhart, Claudio Rapezzi et al.|European Heart Journal|2021Cited by 1.1k
Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant HypertensionFelix Mahfoud, Michael Böhm, Murray Esler et al.|Circulation|2011Cited by 569
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized studyDenise Hilfiker‐Kleiner, Johann Bauersachs, Dominik Berliner et al.|European Heart Journal|2017Cited by 334
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology <scp>W</scp> orking <scp>G</scp> roup on <scp>M</scp> yocardial and <scp>P</scp> ericardial <scp>D</scp> iseasesPablo García‐Pavía, Aleš Linhart, Claudio Rapezzi et al.|European Journal of Heart Failure|2021Cited by 330
Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathyAndreas Perrot, Cemil Özcelik, Volker Ruppert et al.|Basic Research in Cardiology|2008Cited by 77